Levofloxacino Kern Pharma

Levofloxacin, the active ingredient in Levofloxacino Kern Pharma, is a fluoroquinolone antibiotic presented as an intravenous solution for injection use. It treats a range of serious bacterial infections, including pneumonia, urinary tract, intra‑abdominal and skin infections, in adult patients. The drug is supplied in a sterile container suitable for hospital infusion sets and provides rapid systemic exposure.

GNH USA supplies Levofloxacino Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality assurance through rigorous testing and adheres to EU regulatory standards for export.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in several organ systems.

Community‑acquired pneumonia: provides bactericidal activity against typical and atypical pathogens, improving respiratory outcomes. Hospital‑acquired pneumonia: targets resistant Gram‑negative and Gram‑positive organisms, aiding recovery in critically ill patients. Complicated urinary tract infections: eliminates uropathogens, including those resistant to other oral agents, facilitating urinary tract clearance. Complicated intra‑abdominal infections: covers mixed aerobic and anaerobic flora, supporting surgical and medical management of intra‑abdominal sepsis. Skin and soft tissue infections: acts against Staphylococcus aureus and Streptococcus species, reducing lesion size and preventing spread.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Severe allergic reactions such as anaphylaxis

When prescribing levofloxacin, clinicians should observe several safety considerations to minimize risk.

- Assess renal function: adjust dose in patients with impaired clearance. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Avoid in patients with known hypersensitivity to fluoroquinolones. - Use with caution in individuals with QT‑prolonging conditions or concurrent QT‑affecting drugs. - Store at below 25°C: keep in the original container, protect from moisture and light.

Levofloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption; separate administration by at least 2 hours. - Warfarin: may increase INR and bleeding risk; require close monitoring. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of CNS stimulation and seizures.

Moderate Interactions (Monitor Closely): - QT‑prolonging agents (e.g., macrolides, other fluoroquinolones): additive effect on cardiac repolarization. - Corticosteroids: increased risk of tendon rupture.